Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Dejerine-Thomas Syndrome

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Dejerine-Thomas Syndrome in 2 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hatziefthimiou, A1
Mitsacos, A1
Mitsaki, E1
Plaitakis, A1
Kouvelas, ED1
Makowiec, RL1
Albin, RL1
Cha, JH1
Young, AB1
Gilman, S1

Other Studies

2 other studies available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Dejerine-Thomas Syndrome

ArticleYear
Quantitative autoradiographic study of L-glutamate binding sites in normal and atrophic human cerebellum.
    Journal of neuroscience research, 1991, Volume: 28, Issue:3

    Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Adolescent; Adult; alpha-Amino-3-

1991
Two types of quisqualate receptors are decreased in human olivopontocerebellar atrophy cerebellar cortex.
    Brain research, 1990, Jul-23, Volume: 523, Issue:2

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Autoradiography; Cerebellar Cortex; Glutam

1990